TCL Archive Velcade Plus Dexamethasone Provides 20% Response In First-Line Treatment December 29, 2006
TCL Archive Ramucirumab Improves Overall Survival, Progression-Free Survival in Phase III Trial October 26, 2012
TCL Archive In Brief: Wyngaarden Suspends NIH Funds for Pennsylvania Head Injury Center Over Animal Care Problems July 26, 1985
TCL Archive Surgical Oncology Status A Disaster, DCT board Told; Kramer Describes Radiotherapy Needs April 20, 1979